ROTE WILLIAM E.
Chief Research Officer
Officer
Latest Insider Transactions
10 transactions (past 365 days)
| 2026-05-07 | 2026-05-06 | TVTX Travere Therapeutics, Inc. | CRO | Sale | 2,763 | $43.95 | $121,434 |
| 2026-05-07 | 2026-05-04 | TVTX Travere Therapeutics, Inc. | CRO | Exercise Conversion | 4,250 | $0.00 | $0 |
| 2026-04-23 | 2026-04-22 | TVTX Travere Therapeutics, Inc. | CRO | Sale | 9,100 | $39.09 | $355,719 |
| 2026-04-16 | 2026-04-13 | TVTX Travere Therapeutics, Inc. | CRO | Award | 14,000 | $0.00 | $0 |
| 2026-02-03 | 2026-02-03 | TVTX Travere Therapeutics, Inc. | CRO | Sale | 12,446 | $32.87 | -$409,100 |
| 2026-02-03 | 2026-01-31 | TVTX Travere Therapeutics, Inc. | CRO | Award | 20,090 | $0.00 | $0 |
| 2026-02-03 | 2026-01-31 | TVTX Travere Therapeutics, Inc. | CRO | Award | 53,570 | $33.10 | $1,772,899 |
| 2025-12-29 | 2025-12-24 | TVTX Travere Therapeutics, Inc. | CRO | Sale | 60,000 | $40.10 | -$2,406,180 |
| 2025-12-29 | 2025-12-24 | TVTX Travere Therapeutics, Inc. | CRO | Exercise Conversion | 60,000 | $0.00 | $0 |
| 2025-12-29 | 2025-12-24 | TVTX Travere Therapeutics, Inc. | CRO | Exercise Conversion | 60,000 | $20.61 | $1,236,600 |
TVTX
CRO
Exercise Conversion
$0
4,250 shares @ $0.00
Filed 2026-05-07Trade 2026-05-04
Travere Therapeutics, Inc.TVTX
CRO
Exercise Conversion
$0
60,000 shares @ $0.00
Filed 2025-12-29Trade 2025-12-24
Travere Therapeutics, Inc.TVTX
CRO
Exercise Conversion
$1.2M
60,000 shares @ $20.61
Filed 2025-12-29Trade 2025-12-24
Travere Therapeutics, Inc.